Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2343)
All Articles published online
|
Aug 7, 2005 (publication date) through Dec 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pellicano R, Craxì A, Almasio PL, Valenza M, Venezia G, Alberti A, Boccato S, Demelia L, Sorbello O, Picciotto A, Torre F, Ideo G, Cattaneo C, Berrutti M, Rizzetto M. Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C. World J Gastroenterol 2005; 11(29): 4484-4489 [PMID: 16052676 DOI: 10.3748/wjg.v11.i29.4484] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i29/4484.htm |
| Number | Citing Articles |
| 1 |
Seyed Mohammadmehdi Hosseini-Moghaddam, Afkham Mousavi, Seyed Moayed Alavian. Is β-interferon a promising therapeutic option for the management of hepatitis C?. Journal of Antimicrobial Chemotherapy 2009; 63(6): 1097 doi: 10.1093/jac/dkp092
|
| 2 |
Giovanni Clemente Actis, Alda Olivero, Marco Lagget, Rinaldo Pellicano, Antonina Smedile, Mario Rizzetto. The Practice of Percutaneous Liver Biopsy in a Gastrohepatology Day Hospital: A Retrospective Study on 835 Biopsies. Digestive Diseases and Sciences 2007; 52(10): 2576 doi: 10.1007/s10620-006-9724-x
|
| 3 |
Sang Hoon Ahn, Hyun Woong Lee, Yong Soo Kim, Ja Kyung Kim, Kwang-Hyub Han, Chae Yoon Chon, Young Myoung Moon. Recombinant Interferon-Beta-1a Plus Ribavirin for the Treatment of Chronic HCV Infection: A Prospective, Randomized, Comparative Pilot Study. Gut and Liver 2009; 3(1): 20 doi: 10.5009/gnl.2009.3.1.20
|
| 4 |
Henry L. Y. Chan, Hong Ren, Wan C. Chow, Theodore Wee. Randomized trial of interferon beta‐1a with or without ribavirin in Asian patients with chronic hepatitis C†‡. Hepatology 2007; 46(2): 315 doi: 10.1002/hep.21683
|
| 5 |
Virginia Clark, David R. Nelson. Novel Interferons for Treatment of Hepatitis C Virus. Clinics in Liver Disease 2009; 13(3): 351 doi: 10.1016/j.cld.2009.05.004
|
| 6 |
Yoshio Katamura, Fumitaka Suzuki, Norio Akuta, Hitomi Sezaki, Hiromi Yatsuji, Norihiro Nomura, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Natural Human Interferon .BETA. Plus Ribavirin Combination Therapy in Japanese Patients Infected with Hepatitis C Virus and a High Viral Load. Internal Medicine 2008; 47(21): 1827 doi: 10.2169/internalmedicine.47.1436
|
| 7 |
|
| 8 |
Qunying Han, Zhengwen Liu, Wen Kang, Han Li, Lei Zhang, Ni Zhang. Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. Digestive Diseases and Sciences 2008; 53(8): 2238 doi: 10.1007/s10620-007-0129-2
|
| 9 |
Jeanie McGee, Alireza Minagar. Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge. Journal of the Neurological Sciences 2015; 349(1-2): 1 doi: 10.1016/j.jns.2014.12.033
|
| 10 |
Mikio Zeniya, Keitaro Yokoyama, Noritsugu Imamura, Seizo Murai, Tomohisa Ishikawa, Atsushi Hokari, Kazuhiko Koike, Hiroki Takahashi, Syunichi Sadaoka. Significance of interferon‐β for the treatment of hepatitis C virus infection in hemodialyzed patients. Hepatology Research 2010; 40(9): 862 doi: 10.1111/j.1872-034X.2010.00693.x
|
| 11 |
Ricardo Moreno-Otero, María Trapero-Marugán, Elena Gómez-Domínguez, Luisa García-Buey, JoséA Moreno-Monteagudo. Is interferon-beta an alternative treatment for chronic hepatitis C. World Journal of Gastroenterology 2006; 12(17): 2730-2736 doi: 10.3748/wjg.v12.i17.2730
|
| 12 |
Edward C. Mader, Wael Richeh, Joaquin Maury Ochoa, Lacey L. Sullivan, Amparo N. Gutierrez, Jesus F. Lovera. Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?. Journal of the Neurological Sciences 2015; 349(1-2): 239 doi: 10.1016/j.jns.2014.12.034
|
| 13 |
Reina Sasaki, Tatsuo Kanda, Shingo Nakamoto, Yuki Haga, Masato Nakamura, Shin Yasui, Xia Jiang, Shuang Wu, Makoto Arai, Osamu Yokosuka. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World Journal of Hepatology 2015; 7(8): 1125-1132 doi: 10.4254/wjh.v7.i8.1125
|
| 14 |
Saleh A. Alqahtani, Mark S. Sulkowski. HCV: The Journey from Discovery to a Cure. Topics in Medicinal Chemistry 2019; 31: 97 doi: 10.1007/7355_2018_59
|